Cellular Biomedicine Group, Inc. Business Finance Contracts & Agreements
40 Contracts & Agreements
- Assignment Agreements (1 contract)
- Contribution Agreements (1)
- Credit Agreements (4)
- Facility Agreements (1)
- Investment Agreements (1)
- Loan Agreements (4)
- Pledge Agreements (1)
- Purchase Agreements (10)
- Registration Rights Agreements (2)
- Share Agreements (2)
- Stock Agreements (9)
- Subscription Agreements (3)
- Underwriting Agreements (1)
- BRIDGE LOAN AGREEMENT (Filed With SEC on October 26, 2020)
- Amendment Letter, dated as of August 11, 2020, by and between Cellular Biomedicine Group, Inc. and Winsor Capital Limited in relation to the Bridge Loan Agreement, dated as of... (Filed With SEC on August 12, 2020)
- Bridge Loan Agreement, dated as of August 11, 2020, by and between Cellular Biomedicine Group, Inc. and Yunfeng Capital Limited (Filed With SEC on August 12, 2020)
- China Merchants Bank approval of a credit line of up to RMB 30 million to SBM Shanghai (Filed With SEC on August 12, 2020)
- Nanjing Bank approval of a credit line of up to RMB 30 million to CBMG Wuxi (Filed With SEC on August 12, 2020)
- Nanjing Bank approval of a credit line of up to RMB 30 million to CBMG Wuxi (Filed With SEC on May 6, 2020)
- BRIDGE LOAN AGREEMENT (Filed With SEC on January 29, 2020)
- Facility Improvement and Process Validation Agreement (Filed With SEC on August 29, 2019)
- Underwriting Agreement, dated March 21, 2019, by and among Cellular Biomedicine Group, Inc., Cantor Fitzgerald& Co. and Robert W. Baird & Co. Incorporated, as representatives of... (Filed With SEC on March 22, 2019)
- Pledge Agreement, dated as of January 9, 2019, by and between Cellular Biomedicine Group Ltd. (HK) and China Merchants Bank Co., Ltd., Shanghai Branch (Filed With SEC on January 25, 2019)
- Credit Agreement, dated as of January 19, 2019, by and between Shanghai Cellular Biopharmaceutical Group Ltd. and China Merchants Bank Co., Ltd., Shanghai Branch (Filed With SEC on January 25, 2019)
- Securities Purchase Agreement, dated September 25, 2018, by and among the Company, Novartis Pharma AG and Shanghai Cellular Biopharmaceutical Group Ltd (Filed With SEC on September 27, 2018)
- Registration Rights Agreement, dated September 26, 2018, by and between the Company and Novartis Pharma AG (Filed With SEC on September 27, 2018)
- AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 7, 2018)
- AMENDMENT NO. 1 TO REGISTRATION PURCHASE AGREEMENT (Filed With SEC on February 7, 2018)
- SECURITIES PURCHASE AGREEMENT BY AND AMONG CELLULAR BIOMEDICINE GROUP, INC., WEALTH MAP HOLDINGS LIMITED, EARLS MILL LIMITED, AND BOSUN S. HAU JANUARY 30, 2018 TABLEOF CONTENTS (Filed With SEC on January 31, 2018)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 31, 2018)
- SHARE PURCHASE AGREEMENT (Filed With SEC on December 28, 2017)
- SHARE PURCHASE AGREEMENT (Filed With SEC on December 21, 2017)
- SHARES PURCHASE AGREEMENT (Filed With SEC on February 10, 2016)
- Assignment and Assumption Agreement, dated June 26, 2015 (Filed With SEC on July 2, 2015)
- Asset Purchase Agreement, dated June 8, 2015 (Filed With SEC on July 2, 2015)
- ASSET PURCHASE AGREEMENT by and among BLACKBIRD BIOFINANCE, LLC, as Seller, DR. SCOTT ANTONIA and SAM SHRIVASTAVA as Principals, CELLULAR BIOMEDICINE GROUP, INC. as Parent,... (Filed With SEC on June 12, 2015)
- CELLULAR BIOMEDICINE GROUP, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on April 15, 2015)
- U.S. Patent Purchase Agreement, dated September 26, 2014 (Filed With SEC on October 2, 2014)
- Form of Subscription Agreement (Filed With SEC on June 23, 2014)
- CELLULAR BIOMEDICINE GROUP, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on December 16, 2013)
- SECURITIES PURCHASE AGREEMENT Dated as of December 17, 2012 by and between Eastbridge Investment Group Corp. and Zhang, Hui and MA Platform, Inc. (Filed With SEC on June 18, 2013)
- Entrustment Contract on Listing on a U.S. Stock Market (Filed With SEC on June 18, 2013)
- CONTRIBUTION AGREEMENT (Filed With SEC on February 12, 2013)
- Securities Purchase Agreement by and among the Company, Hui Zhang and MA Platform, Inc., dated December 17, 2012 (Filed With SEC on January 14, 2013)
- Stock Purchase Agreement between EastBridge Investment Group Corporation, and An Lingyan, dated December 14, 2011 (Filed With SEC on January 3, 2012)
- Translated Entrustment Contract on Listing on the U.S. Stock Markets among EastBridge Investment Group Corporation, Hangzhou HaoHai Culture Media Co., Ltd. and China Golden Eagle... (Filed With SEC on November 17, 2011)
- Entrustment Contract on Listing on the U.S. Stock Markets (Filed With SEC on June 7, 2011)
- Entrustment Contract on Listing on the U.S. Stock Markets (Filed With SEC on June 7, 2011)
- Entrustment Contract on Listing on the U.S. Stock Markets (Filed With SEC on June 7, 2011)
- Entrustment Contract on Listing on the U.S. Stock Markets (Filed With SEC on May 16, 2011)
- Bridge Capital Raise Agreement between EastBridge Investment Group Corporation and FIZZA, LLC, dated December 1, 2010 (confidential treatment requested for redacted portions) (Filed With SEC on December 7, 2010)
- Stock Purchase Agreement with Ji-Bo Pipes & Valves Company (Filed With SEC on October 22, 2008)
- Stock Purchase Agreement with Aoxing Corporation (Filed With SEC on October 22, 2008)